1. Anti-infection Cell Cycle/DNA Damage Stem Cell/Wnt Autophagy Metabolic Enzyme/Protease
  2. SARS-CoV Casein Kinase Autophagy 11β-HSD
  3. Emodin

Emodin  (Synonyms: Frangula emodin)

Cat. No.: HY-14393 Purity: 98.95%
SDS COA Handling Instructions

Emodin (Frangula emodin), an anthraquinone derivative, is an anti-SARS-CoV compound. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 (ACE2) interaction. Emodin inhibits casein kinase-2 (CK2). Anti-inflammatory and anticancer effects. Emodin is a potent selective 11β-HSD1 inhibitor with the IC50 of 186 and 86 nM for human and mouse 11β-HSD1, respectively. Emodin ameliorates metabolic disorder in diet-induced obese mice.

For research use only. We do not sell to patients.

Emodin Chemical Structure

Emodin Chemical Structure

CAS No. : 518-82-1

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 61 In-stock
Solution
10 mM * 1 mL in DMSO USD 61 In-stock
Solid
50 mg USD 55 In-stock
100 mg USD 77 In-stock
200 mg USD 143 In-stock
500 mg   Get quote  
1 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 24 publication(s) in Google Scholar

Other Forms of Emodin:

Top Publications Citing Use of Products

    Emodin purchased from MedChemExpress. Usage Cited in: Am J Transl Res. 2020 May 15;12(5):1851-1861.  [Abstract]

    Emodin reverses 5-Fu chemoresistance in CRC via downregulation of PI3K/Akt signaling pathway. SW480/5-Fu cells are treated with 5-Fu or/and Emodin for 72 h. Then, the protein expressions of Bax, Bcl-2, cleaved caspase3, ERK, Akt, p-ERK and p-Akt in SW480/5-Fu cells are investigated by Western-blot.

    Emodin purchased from MedChemExpress. Usage Cited in: Am J Transl Res. 2020 May 15;12(5):1851-1861.  [Abstract]

    Emodin resensitizes SW480/5-Fu cells to 5-Fu. SW480/5-Fu cells are treated with 5-Fu or/and Emodin for 72 h. The proliferation of SW480/5-Fu cell is detected by Ki67 immunofluorescence.

    View All Casein Kinase Isoform Specific Products:

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Emodin (Frangula emodin), an anthraquinone derivative, is an anti-SARS-CoV compound. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 (ACE2) interaction[1]. Emodin inhibits casein kinase-2 (CK2). Anti-inflammatory and anticancer effects[2]. Emodin is a potent selective 11β-HSD1 inhibitor with the IC50 of 186 and 86 nM for human and mouse 11β-HSD1, respectively. Emodin ameliorates metabolic disorder in diet-induced obese mice[3].

    IC50 & Target[1][2][3]

    SARS-CoV

     

    CK2α Wild-type

    1.4 μM (IC50, at ATP concentration is 10 μM)

    CK2α Wild-type

    5.9 μM (IC50, at ATP concentration is 50 μM)

    mouse 11β-HSD1

    86 nM (IC50)

    human 11β-HSD1

    186 nM (IC50)

    Cellular Effect
    Cell Line Type Value Description References
    A-375 IC50
    44.91 μM
    Compound: Emodin
    Cytotoxicity against human A375 cells measured after 24 hrs by MTT assay
    Cytotoxicity against human A375 cells measured after 24 hrs by MTT assay
    [PMID: 27769031]
    A549 EC50
    10.9 μM
    Compound: 25, CACDB1751080
    Antiviral activity against Dengue virus type 2 infected in human A549 cells assessed as decrease in viral E protein production by cell-based flavivirus immunodetection assay
    Antiviral activity against Dengue virus type 2 infected in human A549 cells assessed as decrease in viral E protein production by cell-based flavivirus immunodetection assay
    [PMID: 20108931]
    A549 IC50
    28 μM
    Compound: 29
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    [PMID: 21696954]
    A549 CC50
    30.7 μM
    Compound: 25, CACDB1751080
    Cytotoxicity against human A549 cells after 48 hrs
    Cytotoxicity against human A549 cells after 48 hrs
    [PMID: 20108931]
    AGS IC50
    > 70 μM
    Compound: 1, Emodin
    Cytotoxicity against human AGS cells assessed as cell viability after 24 hrs by MTT assay
    Cytotoxicity against human AGS cells assessed as cell viability after 24 hrs by MTT assay
    [PMID: 22901410]
    BALB/3T3 IC50
    32 μg/mL
    Compound: Emodin
    Cytotoxicity against mouse BALB/3T3 cells assessed as growth inhibition after 48 hrs by Alamar blue assay
    Cytotoxicity against mouse BALB/3T3 cells assessed as growth inhibition after 48 hrs by Alamar blue assay
    [PMID: 23534483]
    BGC-823 IC50
    > 50 μM
    Compound: Emodin
    Cytotoxicity against human BGC823 cells measured after 24 hrs by MTT assay
    Cytotoxicity against human BGC823 cells measured after 24 hrs by MTT assay
    [PMID: 27769031]
    Caco-2 CC50
    > 800 μM
    Compound: 6
    Cytotoxicity against human Caco2 cells measured after 72 hrs by MTT assay
    Cytotoxicity against human Caco2 cells measured after 72 hrs by MTT assay
    [PMID: 27933892]
    Calu-1 IC50
    6.25 μM
    Compound: 10
    Inhibition of human Calu1 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    Inhibition of human Calu1 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    [PMID: 11374975]
    DLD-1 IC50
    28 μM
    Compound: Emodin
    Inhibition of PRL-3-mediated cell migration in human DLD1 cells after 15 hrs by crystal violet staining based microscopic assay
    Inhibition of PRL-3-mediated cell migration in human DLD1 cells after 15 hrs by crystal violet staining based microscopic assay
    [PMID: 22137788]
    DLD-1 IC50
    35 μM
    Compound: Emodin
    Inhibition of PRL-3-mediated cell invasion in human DLD1 cells after 20 hrs using crystal violet staining by Matrigel invasion assay
    Inhibition of PRL-3-mediated cell invasion in human DLD1 cells after 20 hrs using crystal violet staining by Matrigel invasion assay
    [PMID: 22137788]
    DU-145 IC50
    2.02 μM
    Compound: Emodin
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    Cytotoxicity against human DU145 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    [PMID: 27173800]
    HCT-116 IC50
    3.8 μM
    Compound: 12, NSC 408120
    Growth inhibition of human HCT116 cells overexpressing PI3Kalpha H1047R mutant after 48 hrs by MTT assay
    Growth inhibition of human HCT116 cells overexpressing PI3Kalpha H1047R mutant after 48 hrs by MTT assay
    [PMID: 22212721]
    HCT-116 IC50
    5.3 μM
    Compound: 12, NSC 408120
    Growth inhibition of human HCT116 cells overexpressing PI3Kalpha after 48 hrs by MTT assay
    Growth inhibition of human HCT116 cells overexpressing PI3Kalpha after 48 hrs by MTT assay
    [PMID: 22212721]
    HCT-116 IC50
    5.7 μM
    Compound: 3
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HCT-116 IC50
    6.2 μM
    Compound: 12, NSC 408120
    Growth inhibition of human HCT116 cells after 48 hrs by MTT assay
    Growth inhibition of human HCT116 cells after 48 hrs by MTT assay
    [PMID: 22212721]
    HEK293 IC50
    1.3 μM
    Compound: Emodin
    Cytotoxicity against human HEK293 cells after 2 days by alamar blue assay
    Cytotoxicity against human HEK293 cells after 2 days by alamar blue assay
    [PMID: 22093761]
    HeLa IC50
    15.6 μM
    Compound: 10
    Inhibition of human HeLa cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    Inhibition of human HeLa cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    [PMID: 11374975]
    HepG2 IC50
    > 50 μM
    Compound: Emodin
    Cytotoxicity against human HepG2 cells measured after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells measured after 24 hrs by MTT assay
    [PMID: 27769031]
    HepG2 IC50
    > 70 μM
    Compound: 1, Emodin
    Cytotoxicity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay
    [PMID: 22901410]
    HepG2 IC50
    1.7 μM
    Compound: 8
    Cytotoxicity against human HepG2 cells after 6 days by MTT assay
    Cytotoxicity against human HepG2 cells after 6 days by MTT assay
    [PMID: 29786436]
    HepG2 IC50
    13.1 μM
    Compound: Emodin
    Cytotoxicity against human HepG2 cells after 2 days by alamar blue assay
    Cytotoxicity against human HepG2 cells after 2 days by alamar blue assay
    [PMID: 22093761]
    HepG2 IC50
    5.2 μM
    Compound: 3
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HL-60 IC50
    > 20 μM
    Compound: Emodin
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    [PMID: 20561793]
    K562 IC50
    > 100 μM
    Compound: 10
    Inhibition of human K562 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    Inhibition of human K562 cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    [PMID: 11374975]
    KB IC50
    > 20 μM
    Compound: Emodin
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    Cytotoxicity against human KB cells after 72 hrs by MTT assay
    [PMID: 20561793]
    LoVo IC50
    27 μM
    Compound: 29
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
    [PMID: 21696954]
    MCF7 IC50
    317.4 μM
    Compound: 14
    Cytotoxicity against human MCF7 cells after 48 hrs by PrestoBlue cell viability assay
    Cytotoxicity against human MCF7 cells after 48 hrs by PrestoBlue cell viability assay
    [PMID: 25226568]
    MDA-MB-231 IC50
    > 20 μM
    Compound: Emodin
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
    [PMID: 20561793]
    PC-3 IC50
    35 μM
    Compound: 29
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
    [PMID: 21696954]
    Raji IC50
    43.8 μM
    Compound: 10
    Inhibition of human Raji cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    Inhibition of human Raji cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    [PMID: 11374975]
    SGC-7901 IC50
    5.6 μM
    Compound: 8
    Cytotoxicity against human SGC7901 cells after 6 days by MTT assay
    Cytotoxicity against human SGC7901 cells after 6 days by MTT assay
    [PMID: 29786436]
    SGC-7901 IC50
    61.3 μM
    Compound: Emodin
    Cytotoxicity against human SGC7901 cells after 2 days by alamar blue assay
    Cytotoxicity against human SGC7901 cells after 2 days by alamar blue assay
    [PMID: 22093761]
    SK-MEL-28 IC50
    35 μM
    Compound: 29
    Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay
    Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay
    [PMID: 21696954]
    THP-1 IC50
    32 μg/mL
    Compound: Emodin
    Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by Alamar blue assay
    Cytotoxicity against human THP1 cells assessed as growth inhibition after 48 hrs by Alamar blue assay
    [PMID: 23534483]
    U-373MG ATCC IC50
    31 μM
    Compound: 29
    Cytotoxicity against human U373 cells after 72 hrs by MTT assay
    Cytotoxicity against human U373 cells after 72 hrs by MTT assay
    [PMID: 21696954]
    Vero IC50
    40 μM
    Compound: 10
    Inhibition of african green monkey Vero cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    Inhibition of african green monkey Vero cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    [PMID: 11374975]
    Vero C1008 CC50
    68.6 μM
    Compound: 50
    Cytotoxicity against African green monkey Vero E6 cells measured up to 24 to 72 hrs by MTT assay
    Cytotoxicity against African green monkey Vero E6 cells measured up to 24 to 72 hrs by MTT assay
    [PMID: 31549836]
    WISH IC50
    28.8 μM
    Compound: 10
    Inhibition of human WISH cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    Inhibition of human WISH cell proliferation assessed as [3H]thymidine incorporation after 3 days by scintillation counting
    [PMID: 11374975]
    In Vitro

    Emodin (10-400 μM) blocks the binding of S protein to ACE2 in a dose-dependent manner with the IC50 value of 200 μM[1].
    Emodin (5-50 μM) inhibits the S protein-pseudotyped retrovirus infectivity in a dose-dependent manner. Emodin blocks the SARS-CoV S protein binding to Vero E6 cells[1].
    Emodin inhibits casein kinase-2 (CK2) with IC50s of 5.9, 30.0, and 7.1 μM for CK2α Wild-type, Ile174Ala mutant, and His160Ala mutant at ATP concentration is 50 μM, respectively. The IC50s are 1.40 and 38.00 μM for CK2α Wild-type, and Val66Ala mutant at ATP concentration is 10 μM[2].
    Emodin exhibits low inhibitory activity against mouse and human 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), with an IC50 higher than 1 mM, indicating that Emodin is more than 5000-fold selective for the human and mouse 11β-HSD1 enzymes over the type 2 isoenzyme[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[1]

    Cell Line: Vero E6 cells transfected with the plasmid encoding ACE2
    Concentration: 0, 5, 25, 50 μM
    Incubation Time: 24 hours
    Result: Vero cells treated with 50 μM remained 82.4±3.8% viability, the anti-SARS-CoV activity was not due to toxicity.
    In Vivo

    Emodin (single oral administration of 100 or 200 mg/kg) inhibits 11β-HSD1 activity in normal C57BL/6J male mice[3].
    Emodin (100 mg/kg; oral administration; b.i.d.) improves insulin sensitivity and lipid metabolism, and lowers blood glucose and hepatic PEPCK, and glucose-6-phosphatase mRNA in diet-induced obese (DIO) mice[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: C57BL/6J male mice[3]
    Dosage: 100 or 200 mg/kg
    Administration: Acute administered p.o. ; Two hours later, the mice were killed by cervical dislocation,
    Result: Significantly inhibited liver 11β-HSD1 enzymatic activity by 17.6 and 31.3% and mesenteric fat 11β-HSD1 enzymatic activity by 21.5 and 46.7% at 100 or 200 mg/kg, respectively.
    Animal Model: DIO mice (C57BL/6J male mice were fed a formulated research diet)[3]
    Dosage: 100 mg/kg
    Administration: Oral gavage; twice per day; for 35 days
    Result: Reduced fasting glucose concentrations to 77.2% of the vehicle control mice after 7 days of treatment, and these remained significantly lower throughout the treatment period.
    Exhibited a significant reduction in blood glucose levels at all time-points following oral glucose challenge after 24 days of treatment.
    Evoked a significantly greater reduction in blood glucose values 40 and 90 min after insulin injection after 28 days of treatment.
    The serum insulin level was also significantly reduced, to 66.2% of control mice, after 35 days of treatment.
    Improved the lipid profiles. The serum triglyceride and total cholesterol levels were significantly reduced by 19.3 and 12.5% after 35 days of treatment, respectively.
    Caused a 22.7% reduction of non-esterified free fatty acid (NEFA) level.
    Lowered body weight and appetite from day 18 of the treatment; their body weights were reduced by 13.9% at the end of treatment.
    Clinical Trial
    Molecular Weight

    270.24

    Formula

    C15H10O5

    CAS No.
    Appearance

    Solid

    Color

    Yellow to orange

    SMILES

    O=C1C2=C(C=C(C)C=C2O)C(C3=CC(O)=CC(O)=C31)=O

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    Solvent & Solubility
    In Vitro: 

    Acetone : 10.87 mg/mL (40.22 mM; Need ultrasonic)

    DMSO : 5.41 mg/mL (20.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Ethanol : < 1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.7004 mL 18.5021 mL 37.0041 mL
    5 mM 0.7401 mL 3.7004 mL 7.4008 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 3.33 mg/mL (12.32 mM); Suspened solution; Need ultrasonic

    • Protocol 2

      Add each solvent one by one:  0.5% Methyl cellulose/0.5% Tween-80 in Saline water

      Solubility: 10 mg/mL (37.00 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    Purity & Documentation

    Purity: 98.95%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO / Acetone 1 mM 3.7004 mL 18.5021 mL 37.0041 mL 92.5104 mL
    5 mM 0.7401 mL 3.7004 mL 7.4008 mL 18.5021 mL
    10 mM 0.3700 mL 1.8502 mL 3.7004 mL 9.2510 mL
    15 mM 0.2467 mL 1.2335 mL 2.4669 mL 6.1674 mL
    20 mM 0.1850 mL 0.9251 mL 1.8502 mL 4.6255 mL
    Acetone 25 mM 0.1480 mL 0.7401 mL 1.4802 mL 3.7004 mL
    30 mM 0.1233 mL 0.6167 mL 1.2335 mL 3.0837 mL
    40 mM 0.0925 mL 0.4626 mL 0.9251 mL 2.3128 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Salutation

    Applicant Name *

     

    Email Address *

    Phone Number *

     

    Organization Name *

    Department *

     

    Requested quantity *

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Emodin
    Cat. No.:
    HY-14393
    Quantity:
    MCE Japan Authorized Agent: